Evidence map›Paper›PMID 32126772›Full record

ArticleJournal of the American Society for Mass Spectrometry2020

Response Surface Methodology As a New Approach for Finding Optimal MALDI Matrix Spraying Parameters for Mass Spectrometry Imaging.

Dušan Veličković, Guanshi Zhang, Dejan Bezbradica, Arunima Bhattacharjee, Ljiljana Paša-Tolić, Kumar Sharma, Theodore Alexandrov, Christopher R Anderton, KPMP Consortium

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society for Mass Spectrometry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Batch Effects in MALDI Mass Spectrometry Imaging.Journal of the American Society for Mass Spectrometry · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Dušan VeličkovićEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Guanshi ZhangCenter for Renal Precision Medicine, University of Texas Health-San Antonio, San Antonio, Texas 78284, United States.
Dejan BezbradicaDepartment of Biochemical Engineering and Biotechnology, Faculty of Technology and Metallurgy, University of Belgrade, Belgrade 11000, Serbia.
Arunima BhattacharjeeEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Ljiljana Paša-TolićEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Kumar SharmaCenter for Renal Precision Medicine, University of Texas Health-San Antonio, San Antonio, Texas 78284, United States.
Theodore AlexandrovStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg 69117, Germany.
Christopher R AndertonEnvironmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.ORCID http://orcid.org/0000-0002-6170-1033
KPMP ConsortiumKidney Precision Medicine Project (KPMP), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.
Pacific Northwest National Laboratory · USThe University of Texas Health Science Center at San Antonio · USNational Institute of Diabetes and Digestive and Kidney Diseases · USUniversity of Belgrade · RSUniversity of California San Diego · US

Funding

Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
ConProject-002U2CDK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2021
$21.0M
Spatial Multi-Omics to Profile Metabolic Pathways for Kidney DiseaseU01DK114920 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Christopher R Anderton, Kumar Sharma · 2022 to 2026
$3.9M
Spatial Metabolomics for Human KidneysUH3DK114920 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHARMA, KUMAR · 2019 to 2021
$2.7M
Cleveland Precision Medicine Chronic Kidney Disease CohortUH3DK114908 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI O'TOOLE, JOHN F., POGGIO, EMILIO DANIEL · 2019 to 2021
$900k
Spatial Metabolomics for Human KidneysUG3DK114920 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI SHARMA, KUMAR · 2017 to 2018
$869k
NIDDK NIH HHS U01 DK114920NIDDK NIH HHS U24 DK114886NIDDK NIH HHS U2C DK114886NIDDK NIH HHS UG3 DK114920NIDDK NIH HHS UH3 DK114908NIDDK NIH HHS UH3 DK114920
6 · The paper itself

Abstract

Automated spraying devices have become ubiquitous in laboratories employing matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), in part because they permit control of a number of matrix application parameters that can easily be reproduced for intra- and interlaboratory studies. Determining the optimal parameters for MALDI matrix application, such as temperature, flow rate, spraying velocity, number of spraying cycles, and solvent composition for matrix application, is critical for obtaining high-quality MALDI-MSI data. However, there are no established approaches for optimizing these multiple parameters simultaneously. Instead optimization is performed iteratively (i.e., one parameter at a time), which is time-consuming and can lead to overall nonoptimal settings. In this report, we demonstrate the use a novel experimental design and the response surface methodology to optimize five parameters of MALDI matrix application using a robotic sprayer. Thirty-two combinations of MALDI matrix spraying conditions were tested, which allowed us to elucidate relationships between each of the application parameters as determined by MALDI-MS (specifically, using a 15 T Fourier transform ion cyclotron resonance mass spectrometer). As such, we were able to determine the optimal automated spraying parameters that minimized signal delocalization and enabled high MALDI sensitivity. We envision this optimization strategy can be utilized for other matrix application approaches and MALDI-MSI analyses of other molecular classes and tissue types.

Indexed as

BiopsyFourier AnalysisHumansKidneyLipidsOptical ImagingSolventsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTemperatureLipidsSolventsdelocalization quantificationexperimental designhuman biopsyMETASPACEmolecular annotation

Identifiers

PMID32126772
PMCPMC7293970
OpenAlexW3004812484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.